4.6 Article

Microbial-generated amyloids and Alzheimer's disease (AD)

Journal

FRONTIERS IN AGING NEUROSCIENCE
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2015.00009

Keywords

42 amino acid amyloid-beta peptide (A beta 42); Alzheimer's disease (AD); birefringence; central nervous system (CNS); Congo red; innate immunity; microbiome; toll receptor type 2 (TLR2)

Funding

  1. COBRE III Pilot Project NIH/NIGMS Grant [P30-GM103340]
  2. Research to Prevent Blindness (RPB)
  3. Louisiana Biotechnology Research Network (LBRN)
  4. NIH [NEI EY006311, NIA AG18031, NIA AG038834]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available